15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering Amrize Ltd, 4 rate it Buy or better, 5 sit at Hold, and 2 rate it Sell or worse, a moderate buy consensus. Targets span $40.00 to $65.00, a moderate spread. The average target of $53.00 sits 26% above the current $41.95. Sentiment has cooled somewhat, with Sell ratings rising from 0 to 2 over recent months. On the fundamentals, the Street sees revenue growth near 5% this year and 6% next, consensus EPS building from about $0.68 next quarter toward $2.91 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Moderate Buy
Strong Buy00%
Buy436%
Hold545%
Sell218%
Strong Sell00%
Based on 11 analysts giving stock ratings to Amrize Ltd.
As of Sep, 4 of 11 firms rate AMRZ a Buy (5 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
AMRZ EPS & revenue forecast
EPS · NEXT QUARTER
$0.68
Range $0.58 – $0.73 · 7 analysts · +25% YoY
Next period, 7 analysts expect Amrize Ltd to earn $0.68 a share (range $0.58 – $0.73), versus $0.54 a year earlier. Full-year consensus is $2.48, growing to $2.91 the year after.
REVENUE · NEXT QUARTER
$3.1B
Range $3.0B – $3.4B · 7 analysts · +4% YoY
Revenue is expected to reach $3.1B (range $3.0B – $3.4B), +4.0% year-over-year. Full-year consensus is $12.6B, rising to $13.2B next year.
Top analysts covering Amrize Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AMRZ.
#1
AP
Anthony Pettinari
Citigroup · Rank #115
Buy
$58.00+38.3% to target
Overall win rate
44%
+ Follow
#2
Bryan Blair
Oppenheimer · Rank #214
Buy
$65.00+55.0% to target
Overall win rate
40%
+ Follow
#3
Keith Hughes
Truist Securities · Rank #280
Hold
No targeton AMRZ
Overall win rate
38%
+ Follow
#4
Timna Tanners
Wells Fargo
Buy
$58.00+38.3% to target
Coverage
—
+ Follow
#5
AC
Anthony Codling
RBC Capital
Sell
$48.00+14.4% to target
Coverage
—
+ Follow
AMRZ stock forecast FAQ
What is AMRZ's average 12-month price target?+
The 10 analysts with a live target average $53.00 for Amrize Ltd over the next 12 months, ranging from a $65.00 high to a $40.00 low.
Is AMRZ stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 11 analyst ratings, 4 are Buy or Strong Buy, 5 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for AMRZ?+
The Street-high target is $65.00 (Oppenheimer), and the Street-low is $40.00 (B of A Securities). The average of all 10 active targets is $53.00.
How many Wall Street analysts cover AMRZ?+
11 analysts have an active rating on Amrize Ltd, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering AMRZ?+
Among analysts who currently cover AMRZ, Anthony Pettinari of Citigroup has the strongest overall Quantellect track record (Rank #115). Their current call is Buy with a $58.00 target.
What is Amrize Ltd's projected EPS for next quarter?+
The consensus estimate is $0.68 per share (range $0.58 – $0.73) across 7 analysts. Full-year EPS is projected at $2.48, rising to $2.91 the following year.
How much revenue is Amrize Ltd expected to report next quarter?+
Consensus revenue is $3.1B (range $3.0B – $3.4B). Full-year revenue is projected at $12.6B, growing to $13.2B next year.
Have analysts been upgrading or downgrading AMRZ lately?+
As of Sep, 4 of 11 firms rate AMRZ a Buy (5 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AMRZ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
DA Davidson
